Molecular Formula | C27H30O11 |
Molar Mass | 530.52 |
Density | 1.475±0.06 g/cm3 (20 ºC 760 Torr) |
Melting Point | 252-253℃ |
Boling Point | 801.3±65.0 °C(Predicted) |
Specific Rotation(α) | -28.4 (Py) |
Solubility | DMSO, methanol |
Appearance | Yellow powder or crystal |
pKa | 6.04±0.40(Predicted) |
Storage Condition | 2-8°C |
MDL | MFCD01662755 |
Physical and Chemical Properties | Yellow crystalline powder, soluble in methanol, ethanol, DMSO and other organic solvents, derived from epimedium. |
Reference Show more | 1. Ju Jing, Pan Yuzheng, Peng Ling Ling, Luo Yan. Effects of icariside Ⅱ on sIgA, rBD2 and IL-6 in rats with tracheal intubation [J]. Chinese medical journal, 2019,34(06):1235-1238. 2. Yang Yishun, Zhang Tong, Ding Yue et al. Preparation and HPLC Determination of three icariin secondary products [J]. Chinese patent medicine 2020 042(003):779-782. 3. Caihong Wang, Caishen Wu, Jinlan Zhang, Ying Jin, Systematic considerations for a multicomponent pharmaco kinetic study of Epimedii wushanensis herba, 2015, P 4. Liu, Congyan, et al. "Icariin combined with snailase shows improved intestinal hydrolysis and absorption in osteoporosis rats." Biomedicine & Pharmacotherapy 94 (2017): 1048-1056.https://doi.org/10.1016/j.biopha.2017.07.163 5. Zhou, Jing, et al. "A strategy for rapid discovery of traceable chemical markers in herbal products using MZmine 2 data processing toolbox: A case of Jing Liqueur." Chinese Herbal Medicines (2021). |
biological activity | Icariside I (Icarisid I) is one of the main components of Epimedii Folium, can significantly stimulate cell proliferation and osteoblast differentiation. |
Use | icariside I has the function of improving cardiovascular system function, regulating endocrine and enhancing immunity. for content determination/identification/pharmacological experiments. Pharmacological Efficacy: estrogen-like effects |